Literature DB >> 1953813

The relative toxicity of nonsteroidal antiinflammatory drugs.

J F Fries1, C A Williams, D A Bloch.   

Abstract

Toxicity Index scores were computed from symptoms, laboratory abnormalities, and hospitalizations attributed to nonsteroidal antiinflammatory drug (NSAID) therapy in 2,747 patients with rheumatoid arthritis receiving 5,642 courses of 11 NSAIDs over 8,481 patient-years. Substantial differences in overall toxicity were found, the differences between drugs often being clinically significant (2-3 times as toxic) and highly statistically significant. The results strengthened after adjustment for differing patient characteristics, held generally across multiple ARAMIS (Arthritis, Rheumatism, and Aging Medical Information System) data bank centers, and persisted after use of different techniques for the weighting of side effects. The most toxic side effects were experienced by patients taking indomethacin (mean +/- SEM score 3.99 +/- 0.58), tolmetin sodium (3.96 +/- 0.74), and meclofenamate sodium (3.86 +/- 0.66). Least toxic were coated or buffered aspirin (1.19 +/- 0.10), salsalate (1.28 +/- 0.34), and ibuprofen (1.94 +/- 0.43). The most toxic drugs were generally taken in the lowest relative doses. There are statistical differences in overall toxicity between different NSAIDs as used in rheumatoid arthritis, and these differences are both clinically and statistically significant.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1953813     DOI: 10.1002/art.1780341103

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  29 in total

Review 1.  Safety, cost and effectiveness issues with disease modifying anti-rheumatic drugs in rheumatoid arthritis.

Authors:  J F Fries
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Rheumatology: 7. Basics of therapy.

Authors:  S H Huang
Journal:  CMAJ       Date:  2000-08-22       Impact factor: 8.262

Review 3.  Is there scope for improving the cost-effective prescribing of nonsteroidal anti-inflammatory drugs?

Authors:  K Bloor; A Maynard
Journal:  Pharmacoeconomics       Date:  1996-06       Impact factor: 4.981

4.  A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors.

Authors:  C Brideau; S Kargman; S Liu; A L Dallob; E W Ehrich; I W Rodger; C C Chan
Journal:  Inflamm Res       Date:  1996-02       Impact factor: 4.575

5.  Toxicity of antirheumatic and anti-inflammatory drugs in children.

Authors:  B Flatø; O Vinje; O Førre
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 6.  Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs.

Authors:  L B Barradell; R Whittington; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-02       Impact factor: 4.981

7.  Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial.

Authors:  K Madhu; K Chanda; M J Saji
Journal:  Inflammopharmacology       Date:  2012-12-16       Impact factor: 4.473

8.  Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functions.

Authors:  H Kankaanranta; E Moilanen; H Vapaatalo
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

9.  Clinical, endoscopic and pathologic spectrum of non-steroidal anti-inflammatory drug-induced colitis.

Authors:  Bita Geramizadeh; Alireza Taghavi; Babak Banan
Journal:  Indian J Gastroenterol       Date:  2009-11-24

Review 10.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.